BioLight Life Sciences (BioLight Life Sciences) Price-to-Operating-Cash-Flow : (As of Apr. 27, 2024)

View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences Price-to-Operating-Cash-Flow?

As of today (2024-04-27), BioLight Life Sciences's share price is $32.60. BioLight Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.05. Hence, BioLight Life Sciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for BioLight Life Sciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

BOLT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

BioLight Life Sciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $-0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 4.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 32.10% per year.

During the past 12 years, BioLight Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.10% per year. The lowest was 4.90% per year. And the median was 25.50% per year.

BioLight Life Sciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioLight Life Sciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Price-to-Operating-Cash-Flow Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of BioLight Life Sciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, BioLight Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLight Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLight Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioLight Life Sciences's Price-to-Operating-Cash-Flow falls into.

BioLight Life Sciences Price-to-Operating-Cash-Flow Calculation

BioLight Life Sciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	32.60	/	-0.045
	=

BioLight Life Sciences's Share Price of today is $32.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioLight Life Sciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.05.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioLight Life Sciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (BioLight Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BOLT:Israel

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.